Tango Therapeutics (TNGX) Depreciation and Depletion (2020 - 2026)
Tango Therapeutics has reported Depreciation and Depletion over the past 6 years, most recently at $500000.0 for Q4 2025.
- For Q4 2025, Depreciation and Depletion fell 19.35% year-over-year to $500000.0; the TTM value through Dec 2025 reached $2.3 million, down 7.96%, while the annual FY2025 figure was $2.3 million, 7.96% down from the prior year.
- Depreciation and Depletion for Q4 2025 was $500000.0 at Tango Therapeutics, down from $553000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $632000.0 in Q2 2024 and troughed at $200000.0 in Q1 2021.
- A 5-year average of $483500.0 and a median of $573500.0 in 2022 define the central range for Depreciation and Depletion.
- Biggest five-year swings in Depreciation and Depletion: soared 119.53% in 2022 and later dropped 19.35% in 2025.
- Year by year, Depreciation and Depletion stood at $256000.0 in 2021, then soared by 119.53% to $562000.0 in 2022, then grew by 9.43% to $615000.0 in 2023, then increased by 0.81% to $620000.0 in 2024, then dropped by 19.35% to $500000.0 in 2025.
- Business Quant data shows Depreciation and Depletion for TNGX at $500000.0 in Q4 2025, $553000.0 in Q3 2025, and $625000.0 in Q2 2025.